Our team

Principal Investigators

Mark A. Jenkins, PhD (contact PI)

The University of Melbourne – Melbourne, Victoria, Australia

Dr Jenkins is the Director of the Centre for Epidemiology and Biostatistics at The University of Melbourne (UoM) and Head of the Centre’s Colorectal Cancer Unit, with a 20-year history of leading cancer epidemiological research in collaboration with statisticians, molecular geneticists, clinicians, and computer scientists. Dr Jenkins’ primary research interest, as a genetic epidemiologist, is determining the risks of cancers for carriers of inherited genetic mutations and determining the genetic and environmental factors that are associated with the reduction or increase in these risks (modifiers). Dr Jenkins has led the Colon Cancer Family Registry since 2017 as the Administrative Principal Investigator and has been a Multiple Principal Investigator or co-Investigator since its inception in 1998.

Steven Gallinger, MD

Sinai Health System – Toronto, Ontario, Canada

Dr Gallinger is a surgical oncologist and has a longstanding interest in genetic determinants of prognosis and response to therapy. Dr Gallinger’s group at the Lunenfeld-Tanenbaum Research Institute developed large infrastructures of biospecimens and data that are both clinic-based and population-based in the province of Ontario, Canada. Dr Gallinger has led colorectal and pancreas cancer genetic programs at the University of Toronto for over 30 years. He now leads the Clinical Translation Program at the Ontario Institute for Cancer Research.

Loic Le Marchand, MD, PhD

The University of Hawai’i at Manoa – Manoa, Hawai’i 

Dr Le Marchand is a Professor in the Population Sciences in the Pacific Program (Cancer Epidemiology) and currently serves as Associate Director for Population Sciences and Community Outreach and Engagement (COE) at the University of Hawai’i Cancer Center (UHCC). Dr Le Marchand has published extensively on the role of biological and lifestyle factors in the etiology of cancer, especially addressing racial/ethnic disparities in cancer risk and outcomes. In 2022, Dr Le Marchand was honored by AACR with the Distinguished Lectureship on the Science of Cancer Health Disparities.

Rish K. Pai, MD, PhD

Mayo Clinic – Arizona Scottsdale, Arizona, USA

Dr Pai’s research at the Mayo Clinic focuses on the histopathology of colorectal cancer with particular emphasis on the histologic features that predict prognosis and correlations between morphologic features and underlying molecular alterations. Dr Pai has extensive training and experience in gastrointestinal pathology, including a specialized fellowship in this area and over 12 years as a practicing anatomic pathologist.

Amanda I. Phipps, PhD, MPH

Fred Hutchinson Cancer Center – Seattle, Washington, USA

Dr Phipps is a cancer epidemiologist and faculty member with the University of Washington and the Fred Hutchinson Cancer Center, whose research centers around identifying factors associated with cancer survival. In particular, Dr Phipps is interested in integrating knowledge of tumor biology with information on modifiable and non-modifiable patient attributes to facilitate better understanding of the factors that drive patient prognosis and impact the burden of cancer.

Stephanie L. Schmit, PhD, MPH

Cleveland Clinic – Cleveland, Ohio, USA

Dr Schmidt’s is a genetic and molecular epidemiologist conducting research at the Cleveland Clinic that focuses on the genetic and molecular epidemiology of colorectal cancer (CRC). Dr Schmidt recently led the analysis of one of the largest GWAS of CRC susceptibility conducted to date with the Colon Cancer Family Registry (CCFR), the Colorectal Transdisciplinary (CORECT) study, and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), and has been productively collaborating with CCFR investigators for over a decade.

Iona Cheng, PhD

The University of California San Francisco – San Francisco, California, USA

Dr Cheng is based in the Department of Epidemiology and Biostatistics at the University of California, San Francisco (UCSF). Dr Cheng is also Chief of the Cancer Epidemiology Division, and Member of the Helen Diller Family Comprehensive Cancer Center.  Dr Cheng is a cancer epidemiologist, and the Principal Investigator of multiple National Institutes of Health (NIH)-funded and foundation-funded projects aimed at examining molecular, lifestyle, environmental, and neighborhood factors for their contribution to cancer risk. Dr Cheng’s extensive research program focuses on investigating racial/ethnic differences in cancer incidence and mortality.

Dan Buchanan, PhD

The University of Melbourne – Melbourne, Victoria, Australia

Dr Buchanan leads a multi-disciplinary research group, the Colorectal Oncogenomics Group, which investiagtes the application of genomics and molecular pathology for the precision prevention of colorectal cancer. He has >270 peer-reviewed publications on the aetiology of colorectal and endometrial cancer. He has an honorary appointment within the Genomic Medicine and Familial Cancer Centre at the Royal Melbourne Hospital and is a member of the national eviQ Cancer Genetics Reference Committee where he contributes to the improving the diagnosis and risk management of hereditary cancer and polyposis syndromes. He is a member of the ClinGen-InSiGHT CRC-Polyposis Variant Curation Expert Panel (VCEP) tasked with developing international variant classification guidelines for hereditary colorectal cancer susceptibility genes. He is the PI of the International Genetics of Colonic Polyposis Study (GCPS), the PI of the NHMRC-funded ANGELS study aimed at applying novel genomic approaches to early-onset and suspected Lynch syndrome colorectal and endometrial cancers. He is one of the multi-PIs of the Colon Cancer Family Registry Cohort (CCFRC) for Phase VI (2023-2028) and has been the Co-PI of the Australasian Colorectal Cancer Family Registry (ACCFR) since 2014 and an active member of the CCFRC since 2006 including managing the ACCFR’s biorepository and as a leader of the Genomics and Molecular Pathology research.

Community Representative

John Stubbs, OA

Sydney, New South Wales, Australia

John is a committed and passionate advocate for people affected by cancer and chronic disease. He holds degrees in Accounting and Arts and is a regular speaker at medical conferences in Australia and internationally about health policy, advocacy, clinical trials, clinician training, research, and the benefits of consumer involvement. He was awarded an Honorary Associate of the University of Sydney – School of Medicine in 2009 for work in the promotion of Research and Clinical Trials in Australia and a Recognition Award from the Federal Department of Health in 2011 for – “long standing commitment to advancing the quality of radiation oncology services in this country”.

In January 2023 John was appointed a Member of the Order of Australia (AM) for significant service to community health, particularly to people with cancer.

In May 2023 John was awarded Life Membership of the Australasian Leukaemia and Lymphoma Clinical Trials Group for his service and contribution to the organisation.


Program Manager

Allyson S. Templeton, BS, MS

Fred Hutchinson Cancer Research Center – Seattle, Washington, USA

CCFR Program Manager since 2007, Allyson has a bachelor’s degree in Nutritional Science from University of Washington (UW), a master’s degree in Environmental Science from Western Washington University, as well as a Certificate in Project Management (UW). Other than a few years as a toxicologist, Allyson has been lucky to have worked in human health research, where her passions lie. Allyson is honored to work alongside NCI and external research collaborators to support new research discoveries that improve the lives of those affected by colorectal cancer.

Informatics Manager

Maggie S. Angelakos, BSc

University of Melbourne – Melbourne, Victoria, Australia

Maggie is passionate about improving data integrity and providing high-level support to CCFR study sites and research collaborators world-wide. Maggie has a bachelor’s degree in Biochemistry and Physiology from Monash University and has dedicated her career to working in research. Maggie found her true calling in data management and has served as the Informatics Manager for the Colon CFR since 2013. 

Biospecimens Manager

Abiola (Abi) Oduwole, Hon BSc

Lunenfeld-Tanenbaum Research Institute – Toronto, Ontario, Canada

Abi completed her Hon BSc. in Biology and a certificate in Project Management at the University of Toronto and has certification as a Project Management Professional (PMP) with the Project Management Institute (PMI). Abi has over 20 years laboratory experience, focusing on quality control, maintaining and enhancing best practices.

Site Study Managers

Cary Greenberg, MSc

Ontario Familial Colorectal Cancer Registry (OFCCR) – Toronto, Ontario, Canada

Cary completed an undergraduate degree in nutrition at the University of Guelph, and a MSc at the University of Toronto. Cary has worked as a clinical dietitian, a research dietitian and research project manager for the Diet and Breast Cancer Prevention Study at the Princess Margaret Cancer Centre and a research project manager for a breast cancer clinical research program and the OFCCR at Sinai Health. Cary currently serves a member of the Research Ethics Board at Mount Sinai Hospital.  

Phuong Hoa

Cleveland Clinic – Cleveland, Ohio, USA

Phuong has been at Cleveland Clinic for 15 years, with 8 of those years spent working in research. Phuong has acted as study coordinator on a breast cancer study called Strive, as well as several clinical trials and investigator-initiated studies for Inflammatory Bowel Disease. In May 2022, Phuong joined the team as a CCFR Program Manager for the Cleveland Clinic in Lerner Research Institute-Genomics Medicine.

Australasian Colorectal Cancer Family Registry (ACCFR) Team

The University of Melbourne – Melbourne, Victoria, Australia

Nicole Eggers, Fiona Phillips and Fiona Munro, have made up the ACCFR team for over 8 years. This team manages over 7900 participants and their families, liaising with them to provide ongoing communication, and conducting the four to five yearly follow-ups. The team is very experienced in protocols associated with research projects and the ethical principles of good clinical research.

Hui Chang, BA, MPH

Hawai’i Colorectal Cancer Family Registry (HCCFR) – Manoa, Hawai’i

Hui completed her Bachelor of Arts (BA) and Master of Public Health (MPH) at University of Hawai’i and also has a Japanese language program certificate from Sophia University. Hui has been working as part of the Hawai’i Colon Cancer Family Registry since 1999!

Dustin Bell, BS, MPH

Mayo Colorectal Cancer Family Registry (MCCFR) – Phoenix, Arizona, USA

Dustin earned a Bachelor of Science in Human Biology from the University of Nebraska at Kearney and a Master of Public Health and certificate in Clinical Ethics at Creighton University School of Medicine. Dustin has worked in hospital pharmacy for eight years before transitioning to a Clinical Research Coordinator. Along with the CCFR study, Dustin helps manage other studies at Mayo Clinic’s Center For Individualized Medicine that focus mainly on genomics.

Rachel Malen, BS, MPH

Seattle Familial Colon Cancer Registry (SFCCR) – Seattle, Washington, USA

Rachel has a BS in Molecular Biology and a master’s of Public Health. Managing studies at Fred Hutch for over a decade, Rachel has worked in a variety of research areas including cancer genetics, health disparities, and HIV prevention. Rachel helps oversee all administrative aspects of this project, including developing participant documents and study protocols, and compliance with human subjects regulations in order to ensure scientific integrity.

Laura Allen

University of California San Francisco CCFR (formerly at CPIC)  

Laura has managed large epidemiologic studies over 20 years and is an expert in a wide range of research methods. She has managed the day-to-day operations of several complex population-based cancer research studies involving quantitative and qualitative data collection from ethnically and linguistically diverse cancer patient and non-patient populations, as well as data collection via medical records abstraction and review, focus groups, and via online and mobile platforms.

As the Program Manager for the Northern California site of the Colon Cancer Family Registry, where Ms. Allen is responsible for managing the collection of epidemiologic and biospecimen data among study participants.